NEW YORK (GenomeWeb) – German start-up SpinDiag said on Thursday that it has raised €1.6 million ($1.9 million) in seed funding.

The financing came from three unnamed private investors and will be used to bring its point-of-care screening system to hospitals from its current laboratory environment, the firm said. The technology called SpinDiag one, is being developed for hospital screening of all clinically relevant antibiotic-resistant bacteria at the time patients are admitted.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.